| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1105311946 |
| P356 | DOI | 10.1186/S13046-018-0802-7 |
| P932 | PMC publication ID | 6034319 |
| P698 | PubMed publication ID | 29976244 |
| P50 | author | Aldo Venuti | Q88155041 |
| P2093 | author name string | Antonio Carlos de Freitas | |
| Rita de Cássia Pereira de Lima | |||
| Cristiane Moutinho Lagos de Melo | |||
| Marconi Rego Barros | |||
| Maria Luiza Carneiro Moura Gonçalves Rego Barros | |||
| P2860 | cites work | Cytotoxic T lymphocytes elicited by dendritic cell-targeted delivery of human papillomavirus type-16 E6/E7 fusion gene exert lethal effects on CaSki cells | Q42222552 |
| Early Defensive Mechanisms against Human Papillomavirus Infection | Q26852611 | ||
| Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response | Q26996330 | ||
| Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy | Q28082461 | ||
| Macrophages, innate immunity and cancer: balance, tolerance, and diversity | Q29614352 | ||
| Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer | Q30409053 | ||
| An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy | Q31121276 | ||
| Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions | Q33315601 | ||
| Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. | Q33468660 | ||
| CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma | Q33657026 | ||
| hrHPV E5 oncoprotein: immune evasion and related immunotherapies. | Q33730462 | ||
| High-Risk Human Papillomavirus E7 Alters Host DNA Methylome and Represses HLA-E Expression in Human Keratinocytes | Q33808063 | ||
| Fibroblast heterogeneity in the cancer wound | Q33964324 | ||
| Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas. | Q40444307 | ||
| NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells | Q40618321 | ||
| CD40/CD40 ligand interactions and TNFα treatment reduce activity of P105 promoter of the human papilloma virus-18 in vitro | Q40734291 | ||
| Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. | Q40790307 | ||
| Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells | Q40797208 | ||
| Antigen-presenting cells. Professionals and amateurs | Q40939184 | ||
| High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma. | Q41076095 | ||
| Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells | Q41348852 | ||
| The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy. | Q41684097 | ||
| Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status | Q41692375 | ||
| Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival | Q41739849 | ||
| Implication of HLA-C and KIR alleles in human papillomavirus infection and associated cervical lesions. | Q41754094 | ||
| Association between langerhans cells population and histological grade of oral squamous cell carcinoma | Q41961753 | ||
| Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells. | Q42261545 | ||
| In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer | Q42279298 | ||
| HPV16 tumor associated macrophages suppress antitumor T cell responses. | Q42455932 | ||
| Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma | Q42707140 | ||
| Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells | Q43582877 | ||
| Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity | Q43742143 | ||
| Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells. | Q43824789 | ||
| Association of KIR genes and HLA-C alleles with HPV-related uterine cervical disease in Korean women | Q44251329 | ||
| Evolving immunosuppressive microenvironment during human cervical carcinogenesis | Q44628163 | ||
| Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma. | Q45934145 | ||
| Epithelial-stromal interactions modulating penetration of matrigel membranes by HPV 16-immortalized keratinocytes | Q46107297 | ||
| Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. | Q46127843 | ||
| Combination of all-trans retinoic acid and a human papillomavirus therapeutic vaccine suppresses the number and function of immature myeloid cells and enhances antitumor immunity | Q46207364 | ||
| Clinical Significance of CD163+ and CD68+ Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer | Q47157554 | ||
| HPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6. | Q47593658 | ||
| Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance | Q47817407 | ||
| Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis | Q48197231 | ||
| Correlation of Circulating CD64+/CD163+ Monocyte Ratio and stroma/peri-tumoral CD163+ Monocyte Density with Human Papillomavirus Infected Cervical Lesion Severity | Q49257819 | ||
| Modulation of antigen presenting cell functions during chronic HPV infection. | Q49591682 | ||
| Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma. | Q50918790 | ||
| Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer. | Q51744221 | ||
| Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. | Q54568958 | ||
| Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer. | Q54637708 | ||
| Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers. | Q55003290 | ||
| Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression. | Q55265921 | ||
| Up-regulation of Inhibitory Natural Killer Receptors CD94/NKG2A with Suppressed Intracellular Perforin Expression of Tumor-Infiltrating CD8+T Lymphocytes in Human Cervical Carcinoma | Q58377175 | ||
| Functional interactions between dendritic cells and NK cells during viral infection | Q60489540 | ||
| Invariant NKT Cells in Hyperplastic Skin Induce a Local Immune Suppressive Environment by IFN- Production | Q62230162 | ||
| Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma | Q74696677 | ||
| Conjugation of HPV16 E7 to cholera toxin enhances the HPV-specific T-cell recall responses to pulsed dendritic cells in vitro in women with cervical dysplasia | Q84520481 | ||
| Therapy for minimal residual tumor disease: beta-galactosylceramide inhibits the growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy | Q84531643 | ||
| Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia | Q86456517 | ||
| Characterization of dendritic cells in lip and oral cavity squamous cell carcinoma | Q86582623 | ||
| HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells | Q34011491 | ||
| Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications | Q34153620 | ||
| Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA vaccine | Q34275134 | ||
| Invariant NKT cells: regulation and function during viral infection | Q34390484 | ||
| HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells | Q34395881 | ||
| Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation | Q34420097 | ||
| HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models | Q34442828 | ||
| Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. | Q34542306 | ||
| HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer | Q34595508 | ||
| Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells | Q34855104 | ||
| MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer | Q34995302 | ||
| HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes. | Q35081677 | ||
| DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells | Q35148074 | ||
| Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation | Q35181633 | ||
| Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. | Q35538088 | ||
| Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia | Q35559432 | ||
| Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. | Q35722714 | ||
| Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer | Q35763382 | ||
| Therapeutic Vaccine Strategies against Human Papillomavirus | Q35826752 | ||
| Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide | Q35886752 | ||
| Prognostic significance of Langerhans cell infiltration in cancer of the larynx. | Q36030743 | ||
| Human papillomavirus immunization is associated with increased expression of different innate immune regulatory receptors | Q36086249 | ||
| Immunology and Immunotherapy of Head and Neck Cancer | Q36100837 | ||
| A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3. | Q36110315 | ||
| Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? | Q36184793 | ||
| Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity | Q36199422 | ||
| Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci | Q36403391 | ||
| NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy | Q36484325 | ||
| Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine. | Q36503451 | ||
| The immune response to papillomavirus during infection persistence and regression | Q36540399 | ||
| Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells | Q36754182 | ||
| Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer | Q36896309 | ||
| Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer. | Q37017190 | ||
| Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14. | Q37123428 | ||
| High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells | Q37126213 | ||
| New Approaches to Immunotherapy for HPV Associated Cancers | Q37137430 | ||
| Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines | Q37140636 | ||
| HPV infection: immunological aspects and their utility in future therapy | Q37145093 | ||
| Progress and challenges in the vaccine-based treatment of head and neck cancers | Q37224926 | ||
| Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies | Q37240985 | ||
| Human papillomavirus, high-grade intraepithelial neoplasia and killer immunoglogulin-like receptors: a Western Australian cohort study | Q37356179 | ||
| Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies | Q37494787 | ||
| High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status | Q37575182 | ||
| CCL2/EGF positive feedback loop between cancer cells and macrophages promotes cell migration and invasion in head and neck squamous cell carcinoma | Q37699365 | ||
| Immunologic treatments for precancerous lesions and uterine cervical cancer | Q37703113 | ||
| Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review | Q37706629 | ||
| Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression | Q37958688 | ||
| The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology. | Q38021154 | ||
| Immunomonitoring and prognostic relevance of neutrophils in clinical trials. | Q38080998 | ||
| Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. | Q38086460 | ||
| Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: a candidate molecule for therapeutic intervention and prognostic biomarker? | Q38277077 | ||
| Tumor-produced, active interleukin-1β regulates gene expression in carcinoma-associated fibroblasts. | Q38373360 | ||
| Therapeutic potential and challenges of natural killer cells in treatment of solid tumors | Q38478878 | ||
| Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma. | Q38731474 | ||
| Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab. | Q38821826 | ||
| Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity | Q38835160 | ||
| HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition | Q38934698 | ||
| Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines | Q38936958 | ||
| Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer | Q38955784 | ||
| LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma | Q38979885 | ||
| HPV16E7 silencing enhances susceptibility of CaSki cells to natural killer cells | Q39021143 | ||
| The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization | Q39168847 | ||
| Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge. | Q39222608 | ||
| Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate. | Q39497510 | ||
| Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. | Q39949375 | ||
| Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy | Q40045752 | ||
| Local and systemic immunomodulatory mechanisms triggered by Human Papillomavirus transformed cells: a potential role for G-CSF and neutrophils. | Q40085054 | ||
| Human Papillomavirus and the Stroma: Bidirectional Crosstalk during the Virus Life Cycle and Carcinogenesis | Q40089345 | ||
| Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma | Q40372949 | ||
| The Interaction Between Human Papillomaviruses and the Stromal Microenvironment | Q40444191 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 1 | |
| P921 | main subject | virus | Q808 |
| neoplasm | Q1216998 | ||
| cell | Q7868 | ||
| tumor virus infections | Q69561737 | ||
| Papillomavirus infections | Q104205912 | ||
| P304 | page(s) | 137 | |
| P577 | publication date | 2018-07-05 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | Activities of stromal and immune cells in HPV-related cancers. | |
| P478 | volume | 37 |
| Q89970071 | Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women |
| Q101574294 | HRRD: a manually-curated database about the regulatory relationship between HPV and host RNA |
| Q92715593 | Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System |
| Q96128113 | STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy |
| Q64084618 | The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer |
| Q91811696 | The value of cytokine levels in triage and risk prediction for women with persistent high-risk human papilloma virus infection of the cervix |
Search more.